Application of CYP1A2-Template System to Understand Metabolic Processes in the Safety Assessment-Reference-Cited by-同舟云学术

Application of CYP1A2-Template System to Understand Metabolic Processes in the Safety Assessment

Published:2022 Issue:4 Volume:10 Page:129-139
ISSN:2187-8404
Container-title:Food Safety
language:en
Short-container-title:Food Safety

Author:

Murayama Norie¹,Yamada Takashi²,Yamazoe Yasushi³

Affiliation:

1. Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan

2. Division of Risk Assessment, Center for Biological Safety Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan

3. Division of Drug Metabolism and Molecular Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai 980-8578, Japan

Publisher

Food Safety Commission, Cabinet Office

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://www.jstage.jst.go.jp/article/foodsafetyfscj/10/4/10_D-22-00008/_pdf

Reference41 articles.

1. 1. Yamazoe Y, Yoshinari K. Prediction of regioselectivity and preferred order of CYP1A1-mediated metabolism: Solving the interaction of human and rat CYP1A1 forms with ligands on the Template system. Drug Metab Pharmacokinet. 2020; 35(1): 165–185. ,PMID:31974042, DOI:10.1016/j.dmpk.2019.10.008

2. 2. Yamazoe Y, Yoshinari K. Prediction of regioselectivity and preferred order of metabolisms on CYP1A2-mediated reactions part 3: Difference in substrate specificity of human and rodent CYP1A2 and the refinement of predicting system. Drug Metab Pharmacokinet. 2019; 34(4): 217–232. ,PMID:31133515, DOI:10.1016/j.dmpk.2019.02.001

3. 3. Yamazoe Y, Yamamura Y, Yoshinari K. Construction of a fused grid-based Template system of CYP2C9 and its application. Drug Metab Pharmacokinet. 2022; 45: 100451. ,PMID:35797783, DOI:10.1016/j.dmpk.2022.100451

4. 4.Yamamura Y, Yoshinari K, Yamazoe Y. Construction of a fused grid-based CYP2C19-Template system and the application. Drug Metab Pharmacokinet. 2022; in press: 100481. DOI:10.1016/j.dmpk.2022.100481

5. 5. Yamazoe Y, Murayama N, Yoshinari K. Refined CYP2E1* Template** system to decipher the ligand-interactions. Drug Metab Pharmacokinet. 2021; 41: 100413. ,PMID:34673327, DOI:10.1016/j.dmpk.2021.100413

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a fused grid-based CYP2C18-Template system and its application to drug metabolism;Drug Metabolism and Pharmacokinetics;2024-02

2. Application of fused-grid-based CYP-Template systems for genotoxic substances to understand the metabolisms;Genes and Environment;2023-08-07

3. Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAF^V600-Mutant Metastatic Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2023-07-20

4. Construction of a fused grid-based CYP2C8-Template system and the application;Drug Metabolism and Pharmacokinetics;2023-01